| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |